1. A system for electricity generation from a plurality of wheeled vehicles moving along a road, the system comprising:
a flap, hingedly connected at a first end at a road level to a frame, and having two states:
(i) a protruding state, in which the flap is inclined upwards and a second end of the flap is above road level, and
(ii) a level state, in which the flap is on a level with the road, wherein the flap is arranged to be moved from the protruding state to the level state by vehicles moving across the flap and pushing down the second end of the flap wherein the flap comprises an extension hingedly connected to the second end to yield a bump like protrusion in the road,
a rack and a pinion, the rack being vertical and jointedly connected by a bar to the second end of the flap, and the pinion being mounted on an input axis and arranged to turn upon vertical movement of the rack due to the vertical pushing down of the second end of the flap by passing vehicles,
a transmission connected to the input axis and arranged to transmit only rotations thereof due to downward movements of the rack to an output axis, and de-couple the input axis from the output axis upon rotations of the former resulting from upward movements of the rack, to accumulate rotations in one direction,
and a flywheel connected to the output axis and arranged to receive the transmitted rotations from the transmission, and operate an alternator over a belt to produce electricity from the accumulated rotation of the flywheel,
wherein said alternator is mounted on an axis spaced apart from said output axis,
wherein the transmission comprises a gear arranged to maintain the rotation of the flywheel within a specified range, and
wherein the flywheel regulates accumulated rotational motion within a specified range of rotational speeds for stabilizing electricity generation at a steady pre-defined rate.
2. The system of claim 1, positioned within a frame below road level.
3. Two systems of claim 1, positioned back to back to generate electricity from two-way traffic.
4. A method of regulating accumulated rotational motion to specified range of rotations speeds for stabilizing electricity generation from a plurality of wheeled vehicles moving along a road to a defined value, comprising:
positioning a hinged protruding flap arranged to generate linear motion of an attached rack upon depression of the flap by a passing vehicle wherein the flap comprises an extension hingedly connected to the second end to yield a bump like protrusion in the road;
converting the linear motion of the rack to a rotational motion of an axis by enabling rotation of the axis in one direction only;
connecting a flywheel, arranged to receive the transmitted rotations from the transmission, to the output axis;
operating an alternator over a belt to produce electricity from the accumulated rotation of the flywheel,
wherein said alternator is mounted on an axis spaced apart from said output axis;
regulating accumulated rotational motion to a specified range of rotation speeds; and
producing electricity from the regulated rotational motion.
5. The method of claim 4, wherein the conversion of linear to rotational motion is carried out by a rack and pinion.
6. The method of claim 5, wherein the enabling rotation of the axis in one direction only is carried out by a transmission arranged to decouple two parts of the axis during an upwards motion of the rack, one part attached to the pinion the other part accumulating rotation the enabled direction.
7. The method of claim 4, further comprising positioning flaps in two traffic directions to generate electricity from two-way traffic.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A layered nanoparticle comprising:
a first biocompatible layer having a substantially concave surface that forms a first outer surface of said layered nanoparticle;
an inner core material layer; and
a second biocompatible layer having a substantially convex surface that forms a second outer surface of the layered nanoparticle, the first and second layers encapsulating the core material layer.
2. The layered nanoparticle of claim 1, wherein said inner core material comprises a material selected from the group consisting of a ferro-magnetic material, a paramagnetic material, a superparamagnetic material, a radioactive material, a pharmaceutical, and a toxin.
3. The layered nanoparticle of claim 1, wherein said inner core material comprises a non-biocompatible material.
4. The layered nanoparticle of 1, wherein said inner core material comprises a ferro-magnetic material.
5. The layered nanoparticle of claim 4, wherein said inner core material comprises a ferro-magnetic material comprising a material selected from the group consisting of iron (Fe), nickel (Ni), cobalt (Co) and gadolinium (Gd), or an alloy thereof, a nitrate nitrite, or nitride thereof, or an oxide thereof.
6. The layered nanoparticle of claim 3, wherein the said inner core material comprises a radioactive material.
7. The layered nanoparticle of claim 5, wherein the said inner core material comprises a radioactive material selected from the group consisting of 125I, 35S, 14C, 32P, 11C, 38K, 89K, 89Zr, 217Bi, 99Tc, 203Pb, 67Ga, 68Ga, 72As, 111In, 113mIn, 97Ru, 62Cu, 64Cu, 52Fe, 52mMn, 51Cr, 186, Re, 188Re, 77As, 90Y, 67Cu, 169Er, 121Sn, 127Te, 142Pr, 143Pr, 198Au, 199Au, 161Tb, 109Pd, 165Dy, 149Pm, 151Pm, 153Sm, 157Gd, 159Gd, 166Ho, 172Tm, 169Yb, 175Yb, 177Lu, 105Rh, 90Y, 131I, 123I, 99In, 131I, 64Cu, 68Ga, and 111Ag.
8. The layered nanoparticle of claim 1, wherein said first biocompatible layer comprises a material selected from the group consisting of gold, aluminum, titanium, niobium, tantalum, nickel, ruthenium, rhodium, palladium, silver, osmium, iridium, platinum, nitenol, and a cobalt base alloy, or an alloy thereof, a nitrate nitrite, or nitride thereof, or an oxide thereof.
9. The layered nanoparticle of claim 8, wherein said first biocompatible layer and said second biocompatible layer comprise the same material.
10. The layered nanoparticle of claim 1, wherein the first biocompatible layer and the second biocompatible layer comprise different materials.
11. The layered nanoparticle of claim 1, wherein said nanoparticle absorbs radiation over a range selected from the group consisting of infrared wavelength visible light wavelength, ultraviolet wavelength, microwave wavelength, and x-ray wavelength.
12. The layered nanoparticle of claim 1, wherein:
said first biocompatible layer comprises gold;
said inner core material comprises cobalt; and
said second biocompatible layer comprises gold.
13. The layered nanoparticle of claim 1, wherein the longest dimension of said nanoparticle is less than or equal to about 500 nm.
14. The layered nanoparticle of claim 1, wherein:
said first biocompatible layer ranges in thickness from about 1 nm to about 50 nm;
said inner core material ranges in thickness from about 1 nm to about 100 nm; and
said second biocompatible layer ranges in thickness from about 1 nm to about 50 nm.
15. The layered nanoparticle of claim 1, wherein said nanoparticle is attached to a moiety selected from the group consisting of a protein, an antibody, a lectin, and a nucleic acid.
16. A method of examining tissue, the method comprising:
introducing nanoparticles into the tissue, wherein each of the nanoparticles comprises
a first biocompatible layer having a substantially concave surface that forms a first outer surface of the nanoparticle,
an inner core material layer, and
a second biocompatible layer having a substantially convex surface that forms a second outer surface of the nanoparticle, the first and second layers encapsulating the core material layer; and
detecting at least some of the nanoparticles by nuclear magnetic resonance, thereby producing nuclear magnetic resonance data.
17. The method of claim 16, further comprising forming a magnetic resonance image from the nuclear magnetic resonance data.
18. The method of claim 16, wherein said administering is by a route selected from the group consisting of parenteral administration, oral administration, rectal administration, inhalation, intravenous administration, intrarterial administration, subdermal administration.
19. The method of claim 16, wherein said nanoparticles are introduced to the tissue at a concentration between about 1 pM and 10 nM.
20. The method of claim 16, wherein said method further comprises detecting at least a portion of the nanoparticles by a modality other than nuclear magnetic resonance.
21. The method of claim 20, wherein said modality comprises a method selected from the group consisting of positron emission tomography, x-ray, cat scan, ultrasound detection and photoacoustic tomography.
22. The method of claim 20, wherein said modality comprises photoacoustic tomography thereby producing photoacoustic tomography data.
23. The method of claim 22, further comprising forming an image from the nuclear magnetic resonance data and the photoacoustic tomography data.
24. The method of claim 16, wherein said examining comprises in vivo imaging of a living human.
25. A method of manufacturing a multi-modal imaging reagent comprising:
using layered nanoparticles, wherein each of the layered nanoparticles comprises
a first biocompatible layer having a substantially concave surface that forms a first outer surface of the nanoparticle,
an inner core material layer, and
a second biocompatible layer having a substantially convex surface that forms a second outer surface of the nanoparticle, the first and second layers encapsulating the core material layer.
26. The method of claim 25, wherein said imaging reagent is formulated for administration to a mammal via a route selected from the group consisting of parenteral administration, oral administration, rectal administration, inhalation, intravenous administration, intrarterial administration, subdermal administration.
27. The method of claim 25, wherein said imaging reagent is formulated at a nanoparticle concentration ranging from about 1 pM to about 10 nM.
28. The method of claim 16, wherein the composition of said nanoparticles is suitable for detection by a modality other than nuclear magnetic resonance.
29. The method of claim 28, wherein said modality comprises a method selected from the group consisting of positron emission tomography, x-ray, cat scan, ultrasound detection and photoacoustic tomography.
30. A method of making a layered nanoparticle, said method comprising:
providing a substrate comprising a plurality of features, each feature providing a convex surface raised above said substrate;
depositing layers on said convex surface to form a nanoparticle, said layers in order comprising
a first biocompatible layer,
an inner core material layer, and
a second biocompatible layer,
performing an etch that separates the nanoparticle from the convex surface.
31. The method of claim 30 further comprising depositing a sacrificial layer on said convex surface before depositing said first biocompatible layer.
32. The method of claim 31, wherein said sacrificial layer comprises a material selected from the group consisting of chromium, molybdenum, tungsten, copper, nickel, and cobalt.
33. The method of claim 30, wherein said features are selected from the group consisting of a nanopillar, a nanosphere, nanowire, and a nanotube.
34. The method of claim 30, wherein:
said providing comprises forming said features on a substrate; and
forming a substantially convex surface on a top of said features.
35. The method of claim 34, wherein said feature is a nanopillar.
36. The method of claim 34, wherein:
said forming said feature comprises forming an array of said features;
forming the substantially convex surface on the top of the feature comprises forming the substantially convex surface of the top of at least a plurality of the features;
depositing the layers on the convex surface comprises depositing the layers on the convex surface of at least a plurality of said features, thereby forming the precursor of a plurality of nanoparticles; and
performing the sacrificial etch separates the nanoparticles from the nanopillars.
37. The method of claim 34, wherein said forming comprises forming a silicon feature on a silicon substrate.
38. The method of claim 37, wherein said feature is a poly-silicon feature.
39. The method of claim 37, wherein said feature andor said substrate is a single crystal silicon feature andor substrate.
40. The method of claim 34, wherein forming the substantially convex surface on the top of the feature comprises forming a silicon oxide nanostructure having a substantially convex shape on the top of said feature.
41. The method of claim 40, wherein forming the silicon oxide nanostructure on the top of said feature comprises heating the silicon feature in an oxygen environment.
42. The method of claim 34 further comprising annealing the features.
43. The method of claim 31, wherein said depositing the sacrificial layer comprises depositing the sacrificial layer material at an angle with respect to an axis of the feature(s) while rotating the substrate, the sacrificial material layer forming the substantially convex surface.
44. The method of claim 30, wherein said performing an etch comprises placing the substrate in a basic solution that dissolves at least a portion of the substrate to release the nanoparticles.
45. The method of claim 44, wherein said basic solution comprises KOH.
46. The method of claim 44 further comprising separating the nanoparticles from the basic solution.
47. The method of claim 30, wherein said inner core material comprises a material selected from the group consisting of a ferro-magnetic material, a paramagnetic material, a superparamagnetic material, a radioactive material, a pharmaceutical, and a toxin.
48. The method of claim 30, wherein said inner core material comprises a non-biocompatible material.
49. The method of claim 30, wherein said inner core material comprises a material selected from the group consisting of cobalt Co, iron (Fe), nickel (Ni), and platinum (Pt), or an alloy thereof, a nitrate nitrite, or nitride thereof, or an oxide thereof.
50. The method of claim 30, wherein the inner core material comprises a ferromagnetic material comprising a material selected from the group consisting of iron (Fe), nickel (Ni), cobalt (Co) and gadolinium (Gd), or an alloy thereof, a nitrate nitrite, or nitride thereof, or an oxide thereof.
51. The method of claim 30, wherein the inner core material comprises a radioactive material.
52. The method of claim 51, wherein the inner core material comprises a radioactive material selected from the group consisting of 125I, 35S, 14C, 32P, 11C, 38K, 89Zr, 217Bi, 99Tc, 203Pb, 67Ga, 68Ga, 72As, 111In, 113mIn, 97Ru, 62Cu, 64Cu, 52Fe, 52mMn, 51Cr, 186, Re, 188Re, 77As, 90Y, 67Cu, 169Er, 121Sn, 127Te, 142Pr, 143Pr, 198Au, 199Au, 161Tb, 109Pd, 165Dy, 149Pm, 151Pm, 153Sm, 157Gd, 159Gd, 166Ho, 172Tm, 169Yb, 175Yb, 177Lu, 105Rh, 90Y, 131I, 123I, 99In, 131I, 64Cu, 68Ga, and 111Ag.
53. The method of claim 30, wherein said first biocompatible layer comprises a material selected from the group consisting of gold, aluminum, titanium, niobium, tantalum, nickel, ruthenium, rhodium, palladium, silver, osmium, iridium, platinum, nitenol, and a cobalt base alloy, or an alloy thereof, a nitrate nitrite, or nitride thereof, or an oxide or hypoxide thereof.
54. The method of claim 53, wherein said first biocompatible layer and said second biocompatible layer comprises the same material.
55. The method of claim 30, wherein the first biocompatible layer and the second biocompatible layer comprise different materials.
56. The method of claim 30, wherein:
said inner core material comprises cobalt;
said first biocompatible layer comprises gold; and
said second biocompatible layer comprises gold.
57. The method of claim 30, wherein the longest dimension of said nanoparticle is less than or equal to about 500 nm.
58. The method of claim 30, wherein:
said first biocompatible layer ranges in thickness from about 1 nm to about 50 nm;
said inner core material ranges in thickness from about 1 nm to about 100 nm; and
said second biocompatible layer ranges in thickness from about 1 nm to about 50 nm.
59. A kit for performing imaging, said kit comprising:
a container containing nanoparticles, wherein each of the nanoparticles comprises
a first biocompatible layer having a substantially concave surface that forms a first outer surface of the nanoparticle,
an inner core material layer, and
a second biocompatible layer having a substantially convex surface that forms a second outer surface of the nanoparticle, the first and second layers encapsulating the core material layer; and
instructional materials teaching the use of said nanoparticles as imaging reagents.
60. The layered nanoparticle of claim 1, wherein said second biocompatible layer comprises a material selected from the group consisting of gold, aluminum, titanium, niobium, tantalum, nickel, ruthenium, rhodium, palladium, silver, osmium, iridium, platinum, nitenol, and a cobalt base alloy, or an alloy thereof, a nitrate nitrite, or nitride thereof, or an oxide thereof.
61. The layered nanoparticle of claim 60, wherein said first biocompatible layer and said second biocompatible layer comprise the same material.
62. The method of claim 30, wherein said second biocompatible layer comprises a material selected from the group consisting of gold, aluminum, titanium, niobium, tantalum, nickel, ruthenium, rhodium, palladium, silver, osmium, iridium, platinum, nitenol, and a cobalt base alloy, or an alloy thereof, a nitrate nitrite, or nitride thereof, or an oxide or hypoxide thereof.
63. The method of claim 62, wherein said first biocompatible layer and said second biocompatible layer comprises the same material.